Quick Takeaways
- David Raben has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,047,713.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David Raben
- Location
- Boston, MA
- Summary
- The estimated net worth of David Raben is at least $1,047,713 dollars as of 26 Mar 2026. David Raben is the Chief Medical Officer of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $1.05M.
- Signature
- /s/ Lara Meisner, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Raben and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Bicara Therapeutics Inc. ($1,047,713).
- Past-year value change for that position: -$1,020,848.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of David Raben
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Chief Medical Officer | $1,047,713 | -$1,020,848 | -49% | 25 Mar 2026 |
Insider Transactions Reported by David Raben:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.